 |
Knox Lane has made a strategic investment in Spectrum Science, which ranks No. 4 on O’Dwyer’s roster of healthcare firms with fee income of $48.9M in 2021.
Focused on the pharma, biotech and life science categories, Spectrum has handled clients such as AbbVie, Moderna, Horizon Therapies, Takeda Neuroscience and Regeneron.
Shamik Patel, Knox Lane partner, and Brent Gunderson, principal, said Spectrum delivers game-changing solutions across commercialization, including strategic communications, advertising, clinical trial recruitment, scientific strategy and medical communications.
Jonathan Wilson, Spectrum owner/CEO, said the firm has “built a team, structure and culture that puts people at the center from the clients we serve, to the patients they help, to the colleagues we collaborate with around the world.”
Spectrum has more than 300 staffers in the US and UK.
Miami’s Newlink Group has acquired Italy’s EJ to strengthen its position in southern Europe, where it has offices in Madrid and Barcelona.
Hodges Partnership co-founders Jon Newman and Josh Dare are selling the Richmond-based firm to four senior VPs who will assume ownership of the shop over the next couple of years.
Interluxe Group, luxury experiential shop, and North & Warren digital-first media agency, have acquired Quinn, the strategic communications shop that services upscale brands.
H/Advisors Abernathy and FGS Global work Keurig Dr Pepper $18B deal to acquire coffee company JDE Peet's. The coffee brands will then be spun off as a separately traded public company.
Shamrock Capital has acquired Penta Group, stakeholder communications firm, from Falfurrias Management Partners.
